Testosterone and Hair Loss: DHT, Genetics and Why High Testosterone Is Not the Cause

Open any men’s health forum this month and you will meet the same confident sentence, repeated in a dozen accents: “If you’re balding, at least it means your testosterone is high.” Its mirror image is just as popular: “Start testosterone therapy and kiss your hairline goodbye.” As of September 2025, both claims are trending again, pushed along by viral short videos, a steady rise in testosterone prescriptions, and renewed curiosity about low-dose oral minoxidil. Searches for testosterone and hair loss have climbed accordingly.

The trouble is that both sentences are wrong in the same way. They treat a hormone as a volume knob, when the real story is about a receptor, an enzyme and the genes you inherited. A man with modest testosterone can lose his hair by thirty; a man with high testosterone can keep a full head into his seventies.

This piece walks through what actually happens inside a shrinking follicle, what the trials and observational studies show, where the evidence is thin, and when a thinning scalp deserves a clinician’s eyes rather than a comment thread.

Does testosterone cause hair loss? The short mechanics

Here is the chain of events in one breath. Testosterone circulates in the blood. Inside certain scalp follicles, an enzyme called 5-alpha reductase converts it into dihydrotestosterone, or DHT, a more potent androgen (an androgen is simply a hormone that produces male-type effects). DHT binds to androgen receptors in the dermal papilla, the small cluster of cells at the base of the follicle that acts as its control center. In follicles that carry a sensitive version of that receptor, the signal gradually shortens the growth phase and shrinks the follicle. Over years, a thick terminal hair becomes a fine, pale vellus hair, then stops appearing at all.

Notice what is not in that chain: the amount of testosterone. Every man and most women have enough circulating testosterone to supply the enzyme. The limiting steps are how much 5-alpha reductase a follicle expresses, how many androgen receptors it carries and how sensitive those receptors are. Those three factors are set largely by genetics, not by how much hormone is on offer.

Hair grows in cycles. The anagen phase, the active growth phase, normally lasts two to six years. Catagen is a brief transition of a couple of weeks. Telogen is a resting phase of around three months, after which the hair sheds and a new one begins. Losing 50 to 100 hairs a day is normal; the NHS and Mayo Clinic both describe that range. In pattern hair loss, DHT does not make hairs fall out faster so much as it makes each new anagen phase shorter and each new hair thinner, a process dermatologists call miniaturization.

So the honest answer to whether testosterone causes hair loss is: testosterone is a necessary ingredient, the way flour is necessary for bread, but it is not the recipe. The recipe is written in the follicle.

What changed recently

The biology has not changed in decades, but the conversation around it has, and a few dated facts explain why the topic is busy right now.

First, the treatment landscape for a different kind of hair loss moved quickly. In June 2022 the US Food and Drug Administration approved baricitinib, the first systemic treatment for severe alopecia areata, an autoimmune condition unrelated to testosterone. Ritlecitinib followed in June 2023 for patients aged 12 and older, and deuruxolitinib in July 2024. These approvals put hair loss in the news, and much of the public did not separate autoimmune hair loss from the hormonal, genetic kind. Cleveland Clinic’s and Mayo Clinic’s patient pages were updated to describe these options, and the references below reflect that.

Second, low-dose oral minoxidil, which is approved as a blood pressure medicine and used off-label for pattern hair loss, became a social media fixture from 2022 onward. The evidence base remains mostly retrospective, a point we return to in the evidence section.

Third, testosterone therapy prescriptions have grown steadily in the United States over the past decade, and with them a wave of first-person videos documenting hairline changes. MedlinePlus Genetics, in its current entry on androgenetic alopecia, continues to describe the condition as affecting an estimated 50 million men and 30 million women in the United States, with the androgen receptor gene on the X chromosome as the best-established genetic contributor. Nothing in that entry supports the viral idea that high testosterone is the driver.

Finally, prescribing information for finasteride in the United States was updated in 2022 to include reports of depression and suicidal thoughts, reinforcing why any decision about that medicine belongs with a prescribing clinician rather than a comment section.

DHT and hair loss: how one enzyme shrinks a follicle

Picture two neighboring follicles on the same scalp, one at the crown and one above the ear. They swim in the same blood, bathed in identical testosterone. By age 45 the crown follicle may have shrunk to a fraction of its former width while the one above the ear is still producing a thick hair. The difference lies in their local machinery.

Follicles in the balding zones of the scalp express more 5-alpha reductase, particularly the type 2 form of the enzyme, and carry more androgen receptors than follicles at the back and sides. Cleveland Clinic’s overview of DHT explains that this hormone binds the androgen receptor several times more tightly than testosterone does, which is why a small amount goes a long way. Studies measuring hormones directly in scalp tissue have found higher DHT in balding scalp than in non-balding scalp from the same person, even when blood levels are identical. The problem is local manufacturing, not national supply.

Once DHT occupies the receptor, the dermal papilla changes the signals it sends to the keratinocytes that build the hair shaft. Growth factors fall, inhibitory signals rise, and each cycle produces a slightly shorter anagen phase. Because anagen length determines how long a hair can grow before it sheds, hairs in affected zones become shorter as well as thinner. Over many cycles the follicle itself sits higher in the skin and its blood supply dwindles.

This is also why the hair at the back of the head, the so-called occipital donor zone, is relatively protected and why transplant surgeons harvest from there. Those follicles keep their insensitivity when moved to the front. The genetic program travels with the follicle, which is perhaps the single most elegant piece of evidence that the follicle, not the hormone environment, is in charge.

Why high testosterone is not the cause: what castration studies and rare genetics showed

The clearest evidence comes from men who lack the ingredient entirely. In the 1940s the anatomist James Hamilton studied men who had been castrated before puberty and found that none developed male pattern baldness. When some were later given testosterone, those with a family history began to bald. Stop the hormone and the process stalled. The lesson was that testosterone is permissive: without it nothing happens, but with it the outcome depends on inheritance.

A second natural experiment emerged in the 1970s with a rare inherited condition, 5-alpha reductase type 2 deficiency. Affected men have normal or high testosterone but cannot convert it efficiently to DHT. They do not develop male pattern hair loss, and their prostates stay small. That observation, reported in the medical literature and summarized by Harvard Health in its discussion of how finasteride was developed, is the reason 5-alpha reductase inhibitors were tested for hair loss at all.

Then there is the population data. Multiple observational studies have compared circulating testosterone in men with and without pattern hair loss. The findings are consistently unimpressive: average total testosterone is similar between the groups, and in some analyses balding men actually have slightly lower levels, partly because baldness correlates with age and age correlates with declining testosterone. No large study has shown that men in the top range of normal testosterone bald more than men in the lower range.

Put those three strands together and the picture is settled. Remove testosterone and baldness does not occur. Remove the ability to make DHT and baldness does not occur. Vary testosterone within the normal range and baldness does not track it. The variable that does predict who thins is the one you cannot measure in a blood test: the sensitivity written into the follicle’s genes.

The genetics of pattern hair loss: more than your mother's father

The folk rule says to look at your maternal grandfather. There is a sliver of truth in it. The androgen receptor gene, called AR, sits on the X chromosome, which men inherit only from their mothers. Variants in AR that make the receptor more active or more abundant are the strongest single genetic association with male pattern hair loss, and MedlinePlus Genetics lists AR as the best-understood contributor.

But a single gene explains only part of the story. Twin studies estimate that heritability of male pattern hair loss is roughly 80 percent, meaning most of the variation between men comes from genes, yet genome-wide studies have now linked well over 200 regions of DNA to the trait. Many sit on ordinary chromosomes inherited from both parents. A father who went bald at 25 is a meaningful warning sign even if the maternal line is thick-haired into old age. Pattern hair loss is polygenic: hundreds of small nudges add up to a threshold.

Why would evolution keep such genes around? Nobody knows for certain. One hypothesis is that the same receptor sensitivity that thins the scalp supports beard growth, muscle response and other androgen-dependent traits that may have been advantageous. Baldness typically appears after peak reproductive years, so natural selection has little reason to remove it.

Practically, genetics explains two things that frustrate people. First, the age of onset and the pattern, whether temples recede first or the crown opens up, often echo a relative’s course. Second, no lifestyle change alters the receptor you were born with. Diet, stress and shampoo can affect the overall health of hair, which matters for other kinds of loss, but they do not rewrite the sensitivity that DHT exploits. That is also why the treatments that work at all for pattern loss target the hormone pathway or the follicle’s growth cycle, not the lifestyle around it.

Testosterone and hair loss in women: female pattern baldness explained

Female pattern baldness, more precisely called female pattern hair loss, is the same disease wearing different clothes. The follicles miniaturize in response to androgens, but the pattern is diffuse thinning over the crown and a widening of the center part, usually with the frontal hairline preserved. Complete bald patches are rare. The Mayo Clinic describes it as the most common cause of hair loss in women, and MedlinePlus Genetics estimates it affects around 30 million women in the United States.

Women produce testosterone too, in roughly a tenth of male amounts, from the ovaries and adrenal glands. For most women with pattern hair loss, blood androgen levels are entirely normal. The follicle sensitivity story applies just as it does in men. A minority, however, do have elevated androgens, most often from polycystic ovary syndrome, and in those women thinning may travel with acne, irregular periods or increased facial hair. That is one reason a clinician evaluating female pattern hair loss will usually ask about those symptoms and may check hormone levels, which is rarely necessary in men.

Timing differs as well. Many women first notice thinning around menopause, when estrogen falls and the balance of hormones acting on the follicle shifts, even though absolute testosterone does not rise. Postpartum shedding, which is a form of telogen effluvium, is a separate and usually temporary event that can be mistaken for pattern loss.

Treatment evidence in women is thinner than in men. Topical minoxidil has randomized trial support and is the only option approved specifically for female pattern hair loss in the United States. Anti-androgen tablets are used off-label in some countries, and 5-alpha reductase inhibitors carry particular cautions in women who could become pregnant. Every one of those decisions sits with the treating clinician, who weighs the woman’s hormonal picture, reproductive plans and other health conditions.

TRT and hair loss: what happens on testosterone therapy

Testosterone replacement therapy, often shortened to TRT, is treatment prescribed for men with clinically low testosterone confirmed by blood tests and symptoms. The viral claim is that it reliably causes balding. The accurate statement is narrower and more useful.

If a man has the genetic sensitivity for pattern hair loss and his testosterone has been low, restoring it to the normal range supplies more substrate for 5-alpha reductase. His follicles may then do what they were always programmed to do, sometimes on a faster timeline than they would have otherwise. In that sense TRT can unmask or accelerate pattern hair loss in a man predisposed to it. If he does not carry the sensitivity, raising his testosterone to normal does not create baldness out of nothing. Hamilton’s castration studies showed exactly this: the men who balded after receiving testosterone were the ones with a family history.

There is also a dose relationship that matters medically. Pushing testosterone above the normal physiological range, as happens with anabolic steroid misuse, delivers more raw material and is associated with accelerated hair loss in susceptible men along with acne and other androgenic effects. Physiological replacement aims to stay within normal limits; non-medical use does not.

What TRT does not do is the opposite claim. Men sometimes hope that treating low testosterone will regrow hair, reasoning that low hormone equals weak hair. There is no evidence for this. Low testosterone is linked with fatigue, reduced libido, low mood and loss of muscle, but pattern hair loss is not among its signs. Thinning hair is not a reason to seek testosterone, and a full head of hair is not a sign that testosterone is adequate.

Anyone on prescribed testosterone who notices accelerated thinning should raise it with the prescribing clinician rather than adjusting or stopping the medicine. There may be options to discuss, and the decision depends on why the therapy was started in the first place.

What the evidence actually says about testosterone and hair loss

Grading the evidence matters, because the strength behind each claim varies enormously.

That DHT, acting on genetically sensitive follicles, drives pattern hair loss is supported by convergent evidence from human genetics, tissue studies and the fact that blocking DHT production alters the disease. This is as close to settled as hair biology gets.

That blood testosterone does not predict who balds rests on observational data, which cannot prove absence of a relationship but has looked repeatedly and found none of substance. Rate this as strong observational evidence.

That 5-alpha reductase inhibitors slow pattern hair loss in men comes from randomized placebo-controlled trials. In the pivotal two-year finasteride trials summarized by Harvard Health, about 83 percent of treated men showed no further loss on scalp photographs versus around 28 percent on placebo, and roughly two-thirds showed some regrowth. Dutasteride, which blocks both enzyme types, has randomized trial data in men but is approved for hair loss in only some countries; elsewhere its use for hair is off-label. These are the highest-quality data in the field.

Topical minoxidil has randomized trials showing increased hair counts in men and women. The effect is moderate, and the mechanism is not hormonal at all; it appears to prolong anagen and improve follicle blood flow.

Low-dose oral minoxidil for pattern hair loss is supported mainly by retrospective case series and small studies. It is off-label everywhere. Rate this as promising but low to moderate quality evidence.

Platelet-rich plasma injections have small, inconsistent randomized trials. Low-level laser devices have some trial data with modest effects. Supplements for people without a deficiency have essentially no trial support, a point the NIH Office of Dietary Supplements makes about biotin.

Anything claiming to “detox DHT” or rebalance hormones through diet alone sits at the level of marketing, not evidence.

Types of hair loss compared: which ones involve hormones at all

Much of the confusion about testosterone and hair loss comes from lumping every thinning scalp into one category. The table below separates the common types by cause, appearance and whether androgens are involved.

Type	Underlying cause	Typical appearance	Androgen-driven?
Male pattern hair loss	Genetic follicle sensitivity to DHT	Receding temples, thinning crown, gradual over years	Yes
Female pattern hair loss	Genetic follicle sensitivity, sometimes with raised androgens	Widening part, diffuse crown thinning, frontal line kept	Yes, usually with normal blood levels
Alopecia areata	Autoimmune attack on follicles	Smooth round patches; short “exclamation point” hairs at edges	No
Telogen effluvium	Stress on the body: illness, surgery, childbirth, crash dieting, some medicines	Diffuse shedding 2–3 months after the trigger, usually recovers	No
Traction alopecia	Repeated pulling from tight styles	Thinning along hairline and part lines	No
Scarring alopecias	Inflammation destroying follicles	Shiny, smooth skin; may itch or burn; permanent	No

Exclamation point hairs deserve a plain definition because so many people search for them: they are short, broken hairs a few millimeters long that are thicker at the tip and narrower near the scalp, like a tiny exclamation mark. They appear at the margins of alopecia areata patches and signal active autoimmune disease, not a hormone problem. Their presence is one of the reasons a clinician can often distinguish alopecia areata from pattern loss by looking closely, sometimes with a handheld magnifier called a dermatoscope.

Telogen effluvium is the other great mimic. A large share of hairs shift into the resting phase at once after a physical shock, then shed together about three months later. People commonly blame a new medicine or supplement started around that time, when the real trigger was a fever or surgery a season earlier.

Common myths about testosterone and hair loss, corrected

Myth: Bald men have more testosterone. Observational studies comparing balding and non-balding men find similar circulating levels. Baldness reflects follicle sensitivity, not hormone quantity. Treating a receding hairline as a badge of virility is flattering but unsupported.

Myth: Testosterone therapy always causes baldness. Restoring low testosterone to normal can accelerate pattern loss in men who were going to lose hair anyway. It does not create the condition in men without the genetic sensitivity. The distinction matters for anyone weighing prescribed therapy with their clinician.

Myth: Low testosterone makes hair fall out. Pattern hair loss is not a sign of low testosterone, and raising testosterone does not regrow hair. The symptoms that genuinely point to low testosterone are different and need blood tests to confirm.

Myth: Blocking DHT lowers your testosterone. 5-alpha reductase inhibitors reduce conversion of testosterone to DHT; blood testosterone typically rises slightly rather than falling. Side effects reported in trials involve sexual function and mood in a minority of users, which is a separate matter from testosterone levels and a reason for clinician supervision.

Myth: Wearing hats, washing too often or using the wrong shampoo causes baldness. None of these alter DHT or receptor sensitivity. Tight styles can cause traction alopecia, which is mechanical and different.

Myth: Shedding 100 hairs a day means you are balding. That number is within the normal daily range described by the NHS. Pattern loss is defined by miniaturization and a changing pattern over months and years, not by a day’s count in the shower drain.

Myth: Natural DHT blockers like saw palmetto or pumpkin seed oil work as well as prescription medicines. The handful of small studies are low quality and inconsistent. The randomized evidence that exists for prescription inhibitors has no equivalent among supplements.

How clinicians tell pattern hair loss from everything else

A good hair consultation is less dramatic than people expect. There is no routine testosterone test for a man with a classic receding hairline, because the result would not change anything. Diagnosis of pattern hair loss is mostly clinical: the distribution of thinning, the family history, the time course and the presence of miniaturized hairs seen under magnification.

What a clinician is really doing is ruling out the conditions in the table above. A gentle pull test, in which a small bunch of hairs is tugged to see how many release, helps distinguish active shedding from slow miniaturization. Dermatoscopy reveals the mix of thick and thin hairs typical of pattern loss, or the exclamation point hairs and yellow dots of alopecia areata, or the loss of follicle openings that marks scarring disease.

Blood tests enter the picture when the story does not fit. Diffuse shedding may prompt checks of thyroid function, iron stores and sometimes vitamin D. In women with pattern loss plus acne, irregular cycles or excess facial hair, androgen levels and other hormone tests help identify polycystic ovary syndrome or, rarely, an androgen-producing tumor. Sudden hair loss with other symptoms such as fatigue, weight change or joint pain may call for broader investigation.

A scalp biopsy, where a tiny core of skin is examined under a microscope, is reserved for cases where scarring is suspected or the picture is unclear, because scarring alopecias can cause permanent loss if inflammation is not controlled early.

The practical point for readers is that photographs matter. Pattern loss is slow, and memory is unreliable. A series of pictures of the crown and hairline under the same light, a few months apart, is often the most useful thing a person can bring to an appointment. It turns a vague worry into something a clinician can assess and, later, use to judge whether a treatment is holding the line.

Established treatments for pattern hair loss, and what they target

Because the problem is a DHT signal landing on a sensitive follicle, approved treatments either reduce the signal or prop up the follicle’s growth cycle. None of them change the genes, which is why benefits persist only while treatment continues. Every option here requires a clinician’s assessment; this is a map, not a menu.

Finasteride, taken by mouth, inhibits the type 2 form of 5-alpha reductase and lowers scalp DHT. It has the strongest randomized trial support in men and is approved for male pattern hair loss in the United States and many other countries. Reported side effects in trials include reduced libido and erectile difficulties in a small percentage of users, and labeling in several countries now also mentions mood changes. Dutasteride inhibits both enzyme types; it is approved for hair loss in some countries, such as South Korea and Japan, and off-label in others. Neither is used in women who could become pregnant because of risk to a male fetus.

Minoxidil applied to the scalp is approved for both men and women. It works on the follicle rather than on hormones, extending the growth phase. Expect several months before judging effect, and an early phase of increased shedding is common as old resting hairs make way for new growth.

Hair transplantation moves DHT-insensitive follicles from the back of the scalp to thinning areas. It is surgery, with the usual surgical considerations, and does not stop ongoing loss elsewhere, which is why surgeons often recommend medical treatment alongside it.

Low-level laser devices have some trial data showing modest increases in hair density. Platelet-rich plasma, where a person’s own concentrated platelets are injected into the scalp, has small and mixed trials.

Harvard Health’s summary of treating male pattern hair loss makes the point that matters most: the earlier treatment begins, the more there is to preserve, because holding ground is more achievable than regrowing it.

What new hair loss treatments are available, and which are still experimental

People searching for new hair loss treatments usually find three things, and they belong in different categories.

The first is genuinely new and genuinely approved, but for a different disease. Janus kinase inhibitors, a class of tablets that calm specific immune signaling pathways, are now approved for severe alopecia areata: baricitinib since June 2022, ritlecitinib since June 2023 and deuruxolitinib since July 2024 in the United States. They do nothing for DHT-driven pattern loss, and they carry boxed safety warnings about infections, blood clots and other risks that make specialist supervision mandatory. Their arrival explains much of the current news coverage.

The second is old medicine in a new form. Low-dose oral minoxidil is a blood pressure tablet repurposed off-label for pattern hair loss. The evidence is mostly retrospective, meaning clinics reviewed records of patients they had treated rather than running controlled trials. Reported side effects include unwanted body hair, swelling in the ankles and dizziness, and because it affects blood pressure and heart rate, it is not a medicine for self-experimentation. Topical finasteride has been approved in parts of Europe since 2022 with the aim of lowering scalp DHT with less systemic exposure; in the United States it is available only through compounding and is not FDA-approved for this use.

The third category is investigational. Research into follicle stem cells, hair cloning, prostaglandin pathways and injectable growth factors continues, and early-phase trials appear regularly. None of these are approved for pattern hair loss, and products sold online as “research peptides” or “hair growth factors” are unregulated and not for sale or self-use. Their safety and content are unverified.

A fair summary is that the most meaningful recent progress has been for autoimmune hair loss, while for pattern hair loss the established medicines remain the evidence-backed core, with low-dose oral minoxidil as a supervised, off-label option under study. Any decision to try it rests with the prescribing clinician.

Natural tips for hair growth at home: what helps, what is harmless and what is wishful

Nothing you do in your kitchen will turn down DHT receptor sensitivity. That said, pattern loss is only one of several things that can happen to a scalp, and some home habits make a measurable difference to overall hair health.

Nutrition matters when something is missing. Iron deficiency, thyroid disorders and severe calorie restriction all cause diffuse shedding, and correcting the deficiency restores growth over months. The NIH Office of Dietary Supplements notes that biotin supplements improve hair only in the rare people who are actually deficient; in everyone else there is no trial evidence of benefit, and high intake can interfere with laboratory tests, including some thyroid and cardiac tests. Eating adequate protein, iron-rich foods and a varied diet is sensible. Megadosing anything is not.

Mechanical gentleness is underrated. Tight braids, ponytails and extensions worn for years cause traction alopecia, which the follicles can recover from if the pulling stops early. Heat styling and chemical relaxers damage the shaft, making hair look thinner through breakage rather than loss at the root. Wide-tooth combs on wet hair and lower heat settings cost nothing.

Scalp massage has a few small studies suggesting it may increase hair thickness, possibly by stretching dermal papilla cells. The evidence is weak, the plausibility is modest and the harm is nil, so it sits in the harmless category.

Smoking is associated with earlier and more severe pattern hair loss in observational studies, probably through effects on follicle blood supply and oxidative stress. Stopping smoking will not regrow a crown, but it is one of the few lifestyle changes with any link to pattern loss at all, and the reasons to do it extend far beyond hair.

Managing stress helps with telogen effluvium, where a shock pushes hairs into shedding. Essential oils, onion juice, rice water and similar viral remedies have little or no controlled evidence. They are mostly harmless on intact skin, but they are not treatments.

When to see a doctor about hair loss or testosterone concerns

Gradual thinning at the temples or crown with a family history is the most common scenario, and it does not need urgent care. It does deserve a conversation with a clinician if it bothers you, because the treatments with the best evidence preserve what remains rather than restore what is gone, and that favors an early appointment over a late one.

Some patterns are red flags and should prompt a prompt visit, ideally with a dermatologist:

• Sudden or rapid loss over weeks rather than years, or hair coming out in clumps.
• Smooth round patches, especially with short broken exclamation point hairs at the edges, which suggest alopecia areata.
• A scalp that is itchy, painful, burning, scaly or has pus-filled bumps, since inflammatory and scarring conditions can cause permanent loss if untreated.
• Shiny, smooth areas where follicle openings have disappeared.
• Hair loss in a woman together with acne, irregular or absent periods, new facial or body hair or a deepening voice, which can signal a hormonal condition.
• Thinning alongside fatigue, unexplained weight change, feeling cold or hot all the time, or other symptoms that suggest thyroid or systemic illness.
• Loss of eyebrows, eyelashes or body hair as well as scalp hair.
• Hair loss starting soon after a new medicine, which should be discussed with the prescriber rather than stopped on your own.

For testosterone itself, hair is not a reason to request a test. If you have symptoms such as persistently low libido, erectile difficulty, loss of morning erections, unexplained fatigue, low mood, reduced muscle or enlarged breast tissue (gynecomastia), that cluster warrants a medical evaluation, which the Mayo Clinic and Cleveland Clinic describe as beginning with a morning blood test repeated for confirmation.

If you are already prescribed testosterone or a hair loss medicine and notice new hair changes, mood changes, sexual side effects, breast tenderness, swelling or dizziness, tell the prescribing clinician. Do not change the dose or stop on your own. Every decision about starting, continuing or combining these medicines belongs to the clinician who knows your full history.

Frequently asked questions

Does testosterone cause hair loss directly?

No. Testosterone must first be converted by the enzyme 5-alpha reductase into dihydrotestosterone (DHT), and DHT acts only on follicles that carry an inherited sensitivity to it. Men castrated before puberty never develop pattern baldness, and men who lack the converting enzyme keep their hair despite normal testosterone. The hormone is a necessary ingredient, but genetics decide the outcome.

Is DHT and hair loss the same problem in men and women?

The mechanism is shared: DHT shrinks genetically sensitive follicles over repeated hair cycles. The pattern differs. Men typically recede at the temples and thin at the crown; women usually thin diffusely over the top with a widening part and a preserved frontal hairline. Most women with pattern loss have normal androgen levels, though a minority have conditions such as polycystic ovary syndrome that raise them.

What is female pattern baldness and how is it treated?

Female pattern baldness, or female pattern hair loss, is gradual thinning over the crown and center part caused by follicle sensitivity to androgens, affecting an estimated 30 million women in the United States. Topical minoxidil has randomized trial support and is the only approved option in the United States. Other medicines are used off-label in some countries, and a clinician will usually check for underlying hormonal causes first.

Will TRT and hair loss always go together?

Not always. Restoring low testosterone to the normal range can accelerate pattern hair loss in men who carry the genetic sensitivity, because it supplies more raw material for DHT. In men without that predisposition, replacement therapy does not create baldness. Anyone on prescribed testosterone who notices faster thinning should discuss it with the prescribing clinician rather than stopping or adjusting the medicine.

Does low testosterone cause hair loss?

No. Pattern hair loss is not a recognized sign of low testosterone, and raising testosterone does not regrow hair. The symptoms that genuinely point toward low testosterone include persistently low libido, erectile difficulty, fatigue, low mood and loss of muscle, confirmed with repeated morning blood tests. A thinning crown on its own is not a reason to seek testosterone testing or treatment.

What is exclamation point hair alopecia?

Exclamation point hairs are short, broken hairs a few millimeters long that are wider at the tip and narrower near the scalp, resembling a tiny exclamation mark. They appear at the margins of smooth round patches in alopecia areata, an autoimmune condition in which the immune system attacks hair follicles. They are not related to testosterone or DHT and usually prompt a referral to a dermatologist.

What are some new hair loss treatments available?

The most significant recent approvals are Janus kinase inhibitors for severe alopecia areata: baricitinib in 2022, ritlecitinib in 2023 and deuruxolitinib in 2024 in the United States. For pattern hair loss, low-dose oral minoxidil is used off-label with mainly retrospective evidence, and topical finasteride is approved in parts of Europe. Stem cell and growth factor approaches remain investigational and are not approved for use.

What are some natural tips for hair growth at home?

Correcting a genuine deficiency in iron or thyroid hormone restores growth over months, but supplements such as biotin have no trial benefit in people who are not deficient. Avoiding tight hairstyles, reducing heat and chemical damage, and stopping smoking all have some supporting evidence. Scalp massage is harmless with weak data. No home remedy alters the follicle sensitivity that drives pattern hair loss.

How many hairs a day is normal to lose?

Losing 50 to 100 hairs a day is normal, according to the NHS and Mayo Clinic, because around 10 percent of scalp hairs are in the resting phase at any time. Pattern hair loss is not defined by daily counts but by hairs becoming progressively finer and shorter in a recognizable distribution. Sudden heavy shedding months after an illness, surgery or childbirth usually reflects telogen effluvium, which typically recovers.

Can hair loss from DHT be reversed?

Partially, in some people, while treatment continues. In randomized trials of 5-alpha reductase inhibitors, roughly two-thirds of men showed some regrowth and most showed no further loss, but follicles that have fully scarred over do not recover. Benefits fade if treatment stops. Because earlier treatment preserves more, clinicians generally favor assessment sooner rather than later. Whether any medicine is appropriate is a decision for the treating clinician.

References

• MedlinePlus Genetics: Androgenetic alopecia
• Cleveland Clinic: DHT (dihydrotestosterone)
• NHS: Hair loss

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.